|1.||Nedogoda, S V: 2 articles (01/2005 - 01/2005)|
|2.||Nishiyama, Akira: 1 article (12/2015)|
|3.||Yahiro, Eiji: 1 article (12/2015)|
|4.||Habe, Shigehisa: 1 article (12/2015)|
|5.||Uehara, Yoshinari: 1 article (12/2015)|
|6.||Miura, Shin-Ichiro: 1 article (12/2015)|
|7.||Devarajan, Sankar: 1 article (12/2015)|
|8.||Saku, Keijiro: 1 article (12/2015)|
|9.||Urata, Hidenori: 1 article (12/2015)|
|10.||Newman, Jonathan: 1 article (01/2008)|
|1.||Hypertension (High Blood Pressure)
06/01/1995 - "Captopril + hydrochlorothiazide was effective and safe in the treatment of mild to moderate hypertension. "
01/01/1986 - "We conclude that a once daily captopril/hydrochlorothiazide combination is effective and safe in elderly patients with mild to moderate hypertension."
07/06/1991 - "The anti-hypertensive effects of the captopril-hydrochlorothiazide combination administered during three months as one single morning dose were evaluated in 51 patients with moderate essential hypertension by means of ambulatory blood pressure recording. "
02/01/1988 - "[Combination captopril-hydrochlorothiazide in a single dose for treatment of essential arterial hypertension]."
01/01/1987 - "Determination of the optimal dosage regimen of captopril + hydrochlorothiazide in the treatment of moderate arterial hypertension."
|2.||Renovascular Hypertension (Goldblatt Syndrome)
12/01/1986 - "The efficacy of captopril, an angiotensin converting enzyme (ACE) inhibitor, and captopril-hydrochlorothiazide (captopril-TZ) in lowering GCP and preventing glomerular damage was evaluated in rats with two-kidney, one clip (2K, 1C) Goldblatt hypertension and partial ablation of the unclipped kidney. "
12/01/1998 - "Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide."
02/15/1995 - "Although the treatment with captopril-hydrochlorothiazide did not modify the hyperhomocysteinemia per se, the therapeutic effects of the drug combination are made evident by the absence of death and ischemic diseases in the M+Cp group. "
02/15/1995 - "We consequently analyzed the therapeutic effects of the captopril-hydrochlorothiazide combination against the typical hyperhomocysteinemia-induced alterations of vascular elastic features. "
|5.||Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/01/1985 - "Treatment with hydralazine or captopril + hydrochlorothiazide controlled blood pressure equally in SHR but had significantly different effects on both left ventricular hypertrophy and resistance vessels. "
12/01/1985 - "Thus, despite equal blood pressure control, thickening of resistance vessel walls regressed more with captopril + hydrochlorothiazide than with hydralazine, suggesting that vascular hypertrophy-like left ventricular hypertrophy is not determined by blood pressure levels alone."
|7.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
|9.||Adrenergic Antagonists (Antiadrenergic Agents)
|1.||Surgical Instruments (Clip)